Authors: Eddahibi, S Humbert, M Sediame, S Chouaid, C Partovian, C Maitre, B Teiger, E Rideau, D Simonneau, C Sitbon, O Adnot, S

Citation: S. Eddahibi et al., Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension - Effect of prostacyclin therapy, AM J R CRIT, 162(4), 2000, pp. 1493-1499

Authors: Partovian, C Adnot, S Raffestin, B Louzier, V Levame, M Mavier, IM Lemarchand, P Eddahibi, S

Citation: C. Partovian et al., Adenovirus-mediated lung vascular endothelial growth factor overexpressionprotects against hypoxic pulmonary hypertension in rats, AM J RESP C, 23(6), 2000, pp. 762-771

Authors: Teiger, E Eloit, M Deprez, I Partovian, C Dubois-Rande, JL Lemarchand, P Adnot, S

Citation: E. Teiger et al., Gene therapy in cardiovascular diseases, M S-MED SCI, 15(5), 1999, pp. 615-624

Authors: Macquin-Mavier, I Partovian, C

Citation: I. Macquin-mavier et C. Partovian, Effects of 17 beta-estradiol on peripheral and coronary vasomotor functionin postmenopausal women, THERAPIE, 54(3), 1999, pp. 353-355

Authors: Partovian, C Adnot, S Eddahibi, S Teiger, E Levame, M Dreyfus, P Raffestin, B Frelin, C

Citation: C. Partovian et al., Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension, AM J P-HEAR, 44(6), 1998, pp. H1948-H1956